Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > 1 year price target.

<< Previous

Bullboard Posts

Next >>

Post by TitanBrawleron Jan 02, 2023 2:04pm

380 Views

Post# 35199696

1 year price target.

Professional analysts projections ™

we predict future values with technical analysis for wide selection of stocks like Oncolytics Biotech, Inc.. If you are looking for stocks with good return, Oncolytics Biotech, Inc. stock can be a bad, high-risk 1-year investment option. Oncolytics Biotech, Inc. real time quote is equal to 1.630 USD at 2023-01-02, but your current investment may be devalued in the future.
1 year price target for Oncy .76usd
...

Hmm..
That's what I thought.

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management